# 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

> **NCT02985099** · PHASE2,PHASE3 · COMPLETED · sponsor: **Government Dental College and Research Institute, Bangalore** · enrollment: 80 (actual)

## Conditions studied

- Chronic Periodontitis
- Type2 Diabetes

## Interventions

- **DRUG:** SRP plus Rosuvastatin gel
- **DRUG:** SRP plus placebo gel

## Key facts

- **NCT ID:** NCT02985099
- **Lead sponsor:** Government Dental College and Research Institute, Bangalore
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985099, "1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02985099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*